secwatch.observer — SEC 8-K summary
======================================

Issuer:     Adagio Medical Holdings, Inc. (ADGM)
CIK:        0002006986
Form:       8-K/A
Filed at:   2024-08-14T23:59:59+00:00
Accession:  0001140361-24-037365
Event type: m_and_a
Sentiment:  positive
Materiality: 0.80
Item codes: 2.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Adagio Medical closes SPAC merger with $84.2M in financing; reports H1 2024 net loss of $14.5M
--------------------------------------------------------------------------------

- Business combination with ARYA Sciences Acquisition Corp IV closed on July 31, 2024, providing ~$84.2 million in financing.
- Transaction costs corrected to ~$13.1 million, including $1M payoff of SVB Term Loan.
- Adagio Medical's H1 2024 revenue $280,000; net loss $14.5 million; cash $2.0 million as of June 30, 2024.
- Working capital deficit of $58.0 million at June 30, 2024; going concern doubt alleviated by merger closing.
- Adagio issued $15.5 million in convertible notes during H1 2024; converted 207,902 preferred shares for pre-funded warrants.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/2006986/000114036124037365/0001140361-24-037365-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/2006986/000114036124037365/ef20034052_8ka.htm
  HTML page:      https://secwatch.observer/filing/0001140361-24-037365

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer